PharmaCare Covid-19 Rapid Point-of-care Test Kit
• Fast results as soon as 10-15 minutes
• Facilitates patient treatment decisions quickly
• Simple, time-saving procedure
• Only 10μL of serum/plasma/whole blood specimen
• All necessary reagents provided & no equipment required
The PharmaCare SARS-CoV-2 IgM/IgG Test Kit is intended for the qualitative detection of SARS-CoV-2 IgM and IgG antibodies in human serum, plasma and whole blood specimens, as an auxiliary diagnosis of COVID-19.
The outbreak of the novel corona virus disease (COVID-19) has created an urgent need for an accurate and rapid test method to quickly identify large number of infected patients and asymptomatic carriers to prevent virus transmission and assure timely treatment of patients. PharmaCare provides rapid and simple point-of-careand at-home lateral flow immunoassays which can detect IgM and IgG antibodies simultaneously against SARS-CoV-2 virus in human blood within 15 minutes and can detect patients at different infection stages.
Based on the principle of colloidal gold immunochromatography to detect the SARS-CoV-2 IgM/IgG antibodies in human serum, plasma and whole blood specimens. When the specimen is added to the specimen well, the specimen is absorbed into the device by capillary action, if the specimen contains SARS-CoV-2 IgM antibody, the antibody will bind to the colloidal gold-labeled SARS-CoV-2 antigen. The antibody/antigen complex will be captured by the anti-human IgM antibody immobilized on the nitrocellulose membrane, forming a red IgM line and indicating an IgM positive result. Similarly as the IgM antibody, if the specimen contains IgG antibody, the IgG line will show a red color and indicate an IgG positive result. If neither antibody is present, a negative result is displayed.